Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Applied Therapeutics Inc. (APLT : NSDQ)

• Company Description    Applied Therapeutics Inc. is a clinical-stage biopharmaceutical company. It engages in developing drug candidates for unmet medical need. The company's product candidate consists of AT-001, for the treatment of Diabetic Cardiomyopathy; AT-007, for the treatment of Galactosemia and AT-003, for the treatment of diabetic retinopathy which are in clinical stage. Applied Therapeutics Inc. is based in New York, United States. Number of Employees: 35

• Price / Volume Information    Yesterday's Closing Price: $0.85 Daily Weekly Monthly 20 Day Moving Average: 2,613,363 shares Shares Outstanding: 144.01 (millions) Market Capitalization: $122.41 (millions) Beta: 2.08 52 Week High: $10.62 52 Week Low: $0.30 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -9.60% -11.97% 12 Week 77.42% 70.06% Year To Date -0.72% -13.22%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 545 5TH AVENUE SUITE 1400 - NEW YORK,NY 10017 USA ph: 212-220-9226 fax: - appliedtherapeutics@argotpartners.com http://www.appliedtherapeutics.com

• General Corporate Information    Officers Les Funtleyder - Interim Chief Executive Officer; Chief Financial O John Johnson - Executive Chairman and Director Constantine Chinoporos - Chief Operating Officer and Chief Business Officer Catherine Thorpe - Interim Chief Accounting Officer Stacy Kanter - Director Peer Information Applied Therapeutics Inc. (CORR.) Applied Therapeutics Inc. (RSPI) Applied Therapeutics Inc. (CGXP) Applied Therapeutics Inc. (BGEN) Applied Therapeutics Inc. (GTBP) Applied Therapeutics Inc. (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 03828A101 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/06/25 Share - Related Items Shares Outstanding: 144.01 Most Recent Split Date: (:1) Beta: 2.08 Market Capitalization: $122.41 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.15 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.59 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/06/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 6.90 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -15.38% vs. Previous Quarter: 0.00% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -15.28% ROE 09/30/25 - - 06/30/25 - -354.24 03/31/25 - -184.67 ROA 09/30/25 - - 06/30/25 - -144.16 03/31/25 - -84.02 Current Ratio 09/30/25 - - 06/30/25 - 1.94 03/31/25 - 3.00 Quick Ratio 09/30/25 - - 06/30/25 - 1.94 03/31/25 - 3.00 Operating Margin 09/30/25 - - 06/30/25 - - 03/31/25 - - Net Margin 09/30/25 - - 06/30/25 - - 03/31/25 - - Pre-Tax Margin 09/30/25 - - 06/30/25 - -55,523.77 03/31/25 - -16,357.52 Book Value 09/30/25 - - 06/30/25 - 0.12 03/31/25 - 0.26 Inventory Turnover 09/30/25 - - 06/30/25 - - 03/31/25 - - Debt-to-Equity 09/30/25 - - 06/30/25 - 0.00 03/31/25 - 0.00 Debt-to-Capital 09/30/25 - - 06/30/25 - 0.00 03/31/25 - 0.00

Powered by Zacks Investment Research ©